BCMA-Targeted Therapies in Myeloma
Practical Insights on Using BCMA-Targeted Therapies in Multiple Myeloma

Released: April 26, 2023

Suzanne Lentzsch
Suzanne Lentzsch, MD, PhD
Joseph Mikhael
Joseph Mikhael, MD, MEd, FRCPC, FACP

Activity

Progress
1
Course Completed

In this episode, Suzanne Lentzsch, MD, PhD, and Joseph Mikhael, MD, MEd, FRCPC, FACP, discuss the role of BCMA-targeted therapies in the management of patients with multiple myeloma, including their experiences and challenges with implementing recent data. This overview will include a discussion of:

  • Considerations with administration, including access challenges
  • Sequencing therapies
  • Future developments with BCMA-targeted therapies